The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2
Phase 1
Completed
- Conditions
- T2DM (Type 2 Diabetes Mellitus)
- Interventions
- Drug: Treatment ADrug: Treatment BDrug: Treatment C
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- AJU Pharm Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT04970940
- Locations
- 🇰🇷
Min-gul Kim, Jeonju, Korea, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath